• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

皮肤T细胞淋巴瘤分子生物学与靶向治疗的新见解

New insights into the molecular biology and targeted therapy of cutaneous T-cell lymphomas.

作者信息

Klemke Claus-Detlev, Goerdt Sergij, Schrama David, Becker Jürgen C

机构信息

Department of Dermatology,Venereologie und Allergology,University Medical Center Mannheim, Ruprecht-Karls University Heidelberg, Mannheim, Germany.

出版信息

J Dtsch Dermatol Ges. 2006 May;4(5):395-406. doi: 10.1111/j.1610-0387.2006.05982.x.

DOI:10.1111/j.1610-0387.2006.05982.x
PMID:16686607
Abstract

Cutaneous T-cell lymphoma is an extra-nodal non-Hodgkin lymphoma of mature T cells. These tumor cells home to and persist in the skin,producing a broad spectrum of clinical entities. Recent results of basic research on tumor biology and tumor immunology as well as molecular genetics of cutaneous T-cell lymphoma have fostered the development of new therapeutic approaches. Several clinical trials testing these targeted therapies have shown encouraging results. This article provides an overview of recent research developments and therapeutic strategies for cutaneous T-cell lymphoma.

摘要

皮肤T细胞淋巴瘤是一种成熟T细胞的结外非霍奇金淋巴瘤。这些肿瘤细胞归巢于皮肤并在其中持续存在,产生广泛的临床病变。最近关于皮肤T细胞淋巴瘤的肿瘤生物学、肿瘤免疫学以及分子遗传学的基础研究成果推动了新治疗方法的发展。几项测试这些靶向疗法的临床试验已显示出令人鼓舞的结果。本文概述了皮肤T细胞淋巴瘤的最新研究进展和治疗策略。

相似文献

1
New insights into the molecular biology and targeted therapy of cutaneous T-cell lymphomas.皮肤T细胞淋巴瘤分子生物学与靶向治疗的新见解
J Dtsch Dermatol Ges. 2006 May;4(5):395-406. doi: 10.1111/j.1610-0387.2006.05982.x.
2
Molecular biology and targeted therapy of cutaneous T-cell lymphomas.皮肤T细胞淋巴瘤的分子生物学与靶向治疗
G Ital Dermatol Venereol. 2008 Dec;143(6):365-74.
3
Targeted nucleic acid delivery into tumors: new avenues for cancer therapy.靶向核酸递送至肿瘤:癌症治疗的新途径
Biomed Pharmacother. 2004 Apr;58(3):152-61. doi: 10.1016/j.biopha.2004.01.003.
4
Efficacy and tolerability of currently available therapies for the mycosis fungoides and Sezary syndrome variants of cutaneous T-cell lymphoma.目前可用疗法对蕈样肉芽肿及皮肤T细胞淋巴瘤Sezary综合征变体的疗效和耐受性。
Cancer Treat Rev. 2007 Apr;33(2):146-60. doi: 10.1016/j.ctrv.2006.08.006. Epub 2007 Feb 1.
5
Drug evaluation: TG-1042, an adenovirus-mediated IFNgamma gene delivery for the intratumoral therapy of primary cutaneous lymphomas.药物评价:TG-1042,一种用于原发性皮肤淋巴瘤瘤内治疗的腺病毒介导的γ干扰素基因递送剂。
Curr Opin Investig Drugs. 2007 Jun;8(6):493-8.
6
Recent developments in carbohydrate-decorated targeted drug/gene delivery.糖基修饰的靶向药物/基因递药系统的最新进展
Med Res Rev. 2010 Mar;30(2):270-89. doi: 10.1002/med.20171.
7
Pathogenesis and therapy of cutaneous lymphomas--progress or impasse?皮肤淋巴瘤的发病机制与治疗——进展还是僵局?
Exp Dermatol. 2006 May;15(5):392-400. doi: 10.1111/j.0906-6705.2006.00419.x.
8
Cutaneous T-cell lymphoma.
Semin Oncol Nurs. 2006 May;22(2):90-6. doi: 10.1016/j.soncn.2006.01.005.
9
Novel therapies for malignant gliomas: a local affair?恶性胶质瘤的新型疗法:局部问题?
Neurosurg Focus. 2006 Apr 15;20(4):E9.
10
Recent advances in cutaneous lymphomas.皮肤淋巴瘤的最新进展
J Dermatol Sci. 2007 Dec;48(3):157-67. doi: 10.1016/j.jdermsci.2007.09.001. Epub 2007 Oct 25.

引用本文的文献

1
Molecular profiling of TOX-deficient neoplastic cells in cutaneous T cell lymphoma.皮肤 T 细胞淋巴瘤中 TOX 缺陷性肿瘤细胞的分子特征分析。
Arch Dermatol Res. 2020 Sep;312(7):513-525. doi: 10.1007/s00403-019-02000-0. Epub 2019 Nov 1.
2
Proteomic Approaches to Biomarker Discovery in Cutaneous T-Cell Lymphoma.皮肤T细胞淋巴瘤生物标志物发现的蛋白质组学方法
Dis Markers. 2016;2016:9602472. doi: 10.1155/2016/9602472. Epub 2016 Oct 16.
3
Ectopic expression of a novel CD22 splice-variant regulates survival and proliferation in malignant T cells from cutaneous T cell lymphoma (CTCL) patients.
一种新型CD22剪接变体的异位表达调节皮肤T细胞淋巴瘤(CTCL)患者恶性T细胞的存活和增殖。
Oncotarget. 2015 Jun 10;6(16):14374-84. doi: 10.18632/oncotarget.3720.
4
BIN1 tumor suppressor regulates Fas/Fas ligand-mediated apoptosis through c-FLIP in cutaneous T-cell lymphoma.BIN1 肿瘤抑制因子通过 c-FLIP 调节皮肤 T 细胞淋巴瘤中的 Fas/Fas 配体介导的细胞凋亡。
Leukemia. 2015 Jun;29(6):1402-13. doi: 10.1038/leu.2015.9. Epub 2015 Jan 12.
5
AHI-1: a novel signaling protein and potential therapeutic target in human leukemia and brain disorders.AHI-1:一种新型信号蛋白,是人类白血病和脑部疾病的潜在治疗靶点。
Oncotarget. 2011 Dec;2(12):918-34. doi: 10.18632/oncotarget.405.
6
[Systemic treatment of cutaneous lymphomas].[皮肤淋巴瘤的全身治疗]
Hautarzt. 2011 Jun;62(6):436-43. doi: 10.1007/s00105-010-2043-3.
7
Proteome-based analysis of serologically defined tumor-associated antigens in cutaneous lymphoma.基于蛋白质组学的血清学定义的皮肤淋巴瘤相关肿瘤抗原分析。
PLoS One. 2009 Dec 18;4(12):e8376. doi: 10.1371/journal.pone.0008376.
8
Serologic and immunohistochemical prognostic biomarkers of cutaneous malignancies.皮肤恶性肿瘤的血清学和免疫组化预后生物标志物。
Arch Dermatol Res. 2007 Mar;298(10):469-77. doi: 10.1007/s00403-006-0726-5.